International Psoriasis Council

Advancing Knowledge. Improving Care.

Caitriona

Ryan

,

MD

Consultant Dermatologist
Institute of Dermatologists Ireland
Ballsbridge
,
Ireland
Councilor Since: May 1, 2015
IPC Councilor
Professor Ryan is a Consultant Dermatologist at the Institute of Dermatologists and Blackrock Clinic, and is a Clinical Professor at University College Dublin. She co-founded the Institute of Dermatologists in 2019. Prof Ryan attained a first class honours medical degree at University College Dublin where she graduated first place in her medical class. She commenced her training as a Dermatology Specialist Registrar at St. Vincent’s Hospital and completed a dermatology residency and research fellowship at the esteemed Baylor Dermatology Residency program in Dallas, Texas. She remained on faculty in Dallas as Clinical Associate Professor of Dermatology for the Texas A+M Health Science Center and Vice Chair of the Department of Dermatology at Baylor University Medical Center, Dallas.

Professor Ryan has published a textbook on psoriasis, 7 book chapters, an encyclopedia chapter, and over 70 articles in peer-reviewed medical journals, including first author articles in JAMA and The Lancet. She regularly presents at international dermatology conferences. She has conducted both scientific and clinical research in psoriasis and has been the Principal Investigator for multiple drug trials in psoriasis and eczema.

Professor Ryan specialises in medical and cosmetic dermatology. Her main areas of medical dermatological interest include psoriasis, skin cancer, acne, atopic dermatitis (eczema), and hair loss.

Professor Ryan has a considerable interest in medical education, particularly with regard to psoriasis education. She was appointed as a councillor of the International Psoriasis Council, and is a Fellow of the American Academy of Dermatology, a Fellow of the Royal College of Physicians Ireland, and a member of the British Association of Dermatologists, the Irish Association of Dermatologists and the British Society for Cutaneous Allergy.
Last Updated:
07/10/2025

Languages Spoken

English

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026